Save on Rytelo with Coupons, Discounts & Savings Programs

Rytelo is an IV infusion used to treat myelodysplastic syndromes (MDS).

Rytelo is available as 47 mg or 188 mg for IV infusion.

Rytelo is an oligonucleotide telomerase inhibitor indicated for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).

Rytelo works by targeting the telomerase enzyme to stop uncontrolled cell division and do not grow. This is helpful in treating conditions like myelodysplastic syndrome (MDS).

The recommended dosage of Rytelo is 7.1 mg/kg given as an intravenous infusion over 2 hours every 4 weeks.

Rytelo is a safe and effective treatment when used for FDA approved indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.

Common side effects of Rytelo: Decreased platelets, white blood cells, and neutrophils Elevated liver enzymes Fatigue Joint and muscle pain Increased PTT Headache

Serious side effects are rare with Rytelo. Contact your healthcare provider immediately if you experience any of the following: Low platelet counts (thrombocytopenia): unusual bleeding or bruising, bleeding that lasts a long time, nosebleeds, vomiting blood, blood in your stools or black tarry stools Low neutrophil counts (neutropenia): signs or symptoms of infection during treatment, including fever, shortness of breath or trouble breathing, cough, chills, or pain or burning when you urinate Infusion-related reactions: sudden increase in blood pressure, stomach pain, joint pain, weakness or fatigue, back and bone pain, diarrhea, redness, headache, not feeling well, chest pain that is not related to your heart

There are no drug interactions listed for Rytelo.

Geron Corporation

Rytelo may harm your unborn baby and may cause loss of pregnancy (miscarriage). Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment. You should use effective birth control (contraception) during treatment with Rytelo and for 1 week after your last dose. Rytelo may also cause fertility problems in females. This could affect your ability to get pregnant. Talk to your healthcare provider if this is a concern for you.

• Imetelstat